Sanofi Taps Foundation Medicine for Biomarker, Companion Dx Discovery | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Foundation Medicine said today that it will use its genome sequencing and analysis services to identify genetic biomarkers and potential companion diagnostics for oncology drug candidates for Sanofi.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.